Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice

Mycoses. 2021 Jul;64(7):694-700. doi: 10.1111/myc.13251. Epub 2021 Feb 12.

Abstract

Onychomycoses are difficult-to-treat fungal infections with a high recurrence rate that relates to the anatomic and pathophysiological conditions in the nail organ and the required extended duration of treatment. Clinical-epidemiological studies demonstrated that non-dermatophyte molds and yeasts are the primary causative agents in 20%-30% of onychomycoses. Mixed infections with dermatophytes are observed as well. Therefore, the causative agents should be determined by fungal culture and the antifungal treatment regimen should reliably cover non-dermatophytes, if appropriate. Systemic-topical combination therapy involving a broad-spectrum, locally applied antifungal may increase the mycological and clinical cure rates compared to monotherapy with systemic drugs.

Keywords: combination therapy; epidemiology; non-dermatophyte mold; onychomycosis; yeast.

Publication types

  • Review

MeSH terms

  • Antifungal Agents / therapeutic use
  • Arthrodermataceae / drug effects
  • Arthrodermataceae / pathogenicity
  • Coinfection / drug therapy
  • Coinfection / microbiology
  • Drug Combinations
  • Fungi* / drug effects
  • Fungi* / pathogenicity
  • Humans
  • Nails / microbiology
  • Onychomycosis* / drug therapy
  • Onychomycosis* / epidemiology
  • Onychomycosis* / microbiology
  • Prevalence
  • Yeasts / drug effects
  • Yeasts / pathogenicity

Substances

  • Antifungal Agents
  • Drug Combinations